von Braun, A, et al.
Antiretroviral therapy [in German]. Therapeutische Umschau
2014; 71: 461–468.
Smith, CJ, et al.
Trends over time in underlying causes of death amongst HIV-positive individuals from 1999 to 2011. Lancet
2014; 384: 241–248.
Marin, B, et al.
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS
2009; 23: 1743–1753.
Kowalska, JD, et al.
The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology; 22. Published online: July 2011. doi:10.1097/EDE.0b013e31821b5332.
Weber, R, et al.
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Medicine
2013; 14: 195–207.
Pacheco, AG, et al.
Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil. Journal of Acquired Immune Deficiency Syndromes
2009; 51: 624–630.
Grinsztejn, B, et al.
Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. PLoS ONE
2013; 8: 59–68.
GBD 2015 HIV Collaborators. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: The Global Burden of Disease Study 2015. Lancet HIV
2016; 3: e361–e387.
Girardi, E, et al.
Impact of previous ART and of ART initiation on outcome of HIV-associated tuberculosis. Clinical and Developmental Immunology. Published online: 12 January 2012. doi:10.1155/2012/931325.
Tadesse, K, Haile, F, Hiruy, N. Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum Hospital, Northern Ethiopia: a retrospective cohort study. PLoS ONE. Published online: 31 January 2014. doi: 10.1371/journal.pone.0087392.
Floyd, S, et al.
The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level – a comparative analysis of data from four settings in Southern and East Africa. Tropical Medicine and International Health
2012; 17: e84–e93.
Helleberg, M, et al.
Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clinical Infectious Diseases
2013; 56: 727–734.
Obel, N, et al.
Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study. PLoS ONE. Published online: 25 July 2011. doi: 10.1371/journal.pone.0022698.
Hernando, V, et al.
Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms. AIDS
2012; 26: 1829–1834.
Pintilie, M. An introduction to competing risks analysis. Revista Española de Cardiología
2011; 64: 599–605.
Brazilian Ministry of Health. HIV/AIDS Epidemiological Bulletin, Brasília, Brazil: Centre of Health Surveillance/Department of STD, AIDS and Viral Hepatitis, 2015.
Batista, DA. The impact of antiretroviral therapy in years of life lost and cause of death by AIDS in Pernambuco - 1990 to 2005 (dissertation). Recife, PE, Brazil: Aggeu Magalhães Research Center, Oswaldo Cruz Foundation, 2010, 100 pp.
Batista, JDL, et al.
Incidence and risk factors for tuberculosis in People living with HIV: Cohort from HIV referral health centers in Recife, Brazil. PLoS ONE. Published online: 10 May 2013. doi: 10.1371/journal.pone.0063916.
Fine, JP, Gray, RJ. A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association
1999; 94: 496–509.
Camargo, KR Jr., Coeli, CM. Reclink: an application for database linkage implementing the probabilistic record linkage method. Cadernos de Saúde Pública
2000; 16: 439–447.
World Health Organization (WHO). Diet, nutrition and the prevention of chronic diseases. Report of a WHO Study Group Geneva, 1990; WHO Technical Report Series (TRS) 90–797; no. 797.
Mocroft, A, et al.
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. AIDS
1999; 13: 943–950.
Brazilian Ministry of Health. Manual of recommendations for the control of tuberculosis in Brazil, Brasília, Brazil: Centre of Health Surveillance/Department of Epidemiological Surveillance, 2011, Series and Technical Manuals, series A.
Golub, JE, et al.
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV infected adults in South Africa: a prospective cohort. AIDS
2009; 23: 631–636.
The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clinical Infectious Diseases
2010; 50: 1387–1396.
Kowalska, JD, et al.
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy. AIDS
2012; 26: 315–323.
Geldmacher, C, et al.
Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. Journal of Experimental Medicine
2010; 207: 2869–2881.
Marcy, O, et al.
Causes and determinants of mortality in HIV infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. Clinical Infectious Diseases
2014; 59: 435–445.
Diedrich, CR, Flynn, JL. HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis?
Infection and Immunity
2011; 79: 1407–1417.
Saraceni, V, et al.
Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil. The International Journal of Tuberculosis and Lung Disease
2008; 12: 769–772.
Vijay, S, et al.
Treatment outcome and mortality at one and half year follow-up of HIV infected TB patients under TB Control Programme in a district of South India. PLoS ONE. Published online: 26 July 2011. doi: 10.1371/journal.pone.0021008.
Kerkhoff, AD, et al.
The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study. BMC Medicine
2015; 13: 70.
Sullivan, PS, et al.
Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood
2014; 91: 301–308.
Tuboi, SH, et al.
Mortality during the first year of potent antiretroviral therapy in HIV-1–infected patients in 7 sites throughout Latin America and the Caribbean. Journal of Acquired Immune Deficiency Syndromes
2009; 51: 615–623.
Sieleunou, I, et al.
Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Tropical Medicine and International Health
2009; 14: 36–43.
Johannessen, A, et al.
Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infectious Diseases
2008; 8: 52.
Wandeler, G, et al.
The J-curve in HIV: better cardiovascular disease free survival with moderate alcohol intake. Journal of Acquired Immune Deficiency Syndromes
2015; 71: 302–309.
Tjepkema, M, Wilkins, R, Long, A. Cause-specific mortality by occupational skill level in Canada: a 16-year follow-up study. Chronic Diseases and Injuries in Canada
2013; 33: 195–203.
Wada, N, et al.
Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984–2008. American Journal of Epidemiology
2013; 177: 116–125.